Research output: Contribution to journal › Article › peer-review
Spirocyclic Scaffolds in Medicinal Chemistry. / Hiesinger, Kerstin; Dar'In, Dmitry; Proschak, Ewgenij; Krasavin, Mikhail.
In: Journal of Medicinal Chemistry, Vol. 64, No. 1, 14.01.2021, p. 150-183.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Spirocyclic Scaffolds in Medicinal Chemistry
AU - Hiesinger, Kerstin
AU - Dar'In, Dmitry
AU - Proschak, Ewgenij
AU - Krasavin, Mikhail
N1 - Publisher Copyright: © Copyright: Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/1/14
Y1 - 2021/1/14
N2 - Spirocyclic scaffolds are incorporated in various approved drugs and drug candidates. The increasing interest in less planar bioactive compounds has given rise to the development of synthetic methodologies for the preparation of spirocyclic scaffolds. In this Perspective, we summarize the diverse synthetic routes to obtain spirocyclic systems. The impact of spirocycles on potency and selectivity, including the aspect of stereochemistry, is discussed. Furthermore, we examine the changes in physicochemical properties as well as in in vitro and in vivo ADME using selected studies that compare spirocyclic compounds to their nonspirocyclic counterparts. In conclusion, the value of spirocyclic scaffolds in medicinal chemistry is discussed.
AB - Spirocyclic scaffolds are incorporated in various approved drugs and drug candidates. The increasing interest in less planar bioactive compounds has given rise to the development of synthetic methodologies for the preparation of spirocyclic scaffolds. In this Perspective, we summarize the diverse synthetic routes to obtain spirocyclic systems. The impact of spirocycles on potency and selectivity, including the aspect of stereochemistry, is discussed. Furthermore, we examine the changes in physicochemical properties as well as in in vitro and in vivo ADME using selected studies that compare spirocyclic compounds to their nonspirocyclic counterparts. In conclusion, the value of spirocyclic scaffolds in medicinal chemistry is discussed.
KW - SMALL-MOLECULE INHIBITORS
KW - RECEPTOR ANTAGONISTS
KW - GPR40 AGONISTS
KW - HIGH-AFFINITY
KW - DISCOVERY
KW - POTENT
KW - FENSPIRIDE
KW - OPTIMIZATION
KW - PROLINE
KW - DESIGN
UR - http://www.scopus.com/inward/record.url?scp=85100069361&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/0b869082-7145-3e69-900f-dc750dcdd82e/
U2 - 10.1021/acs.jmedchem.0c01473
DO - 10.1021/acs.jmedchem.0c01473
M3 - Article
C2 - 33381970
AN - SCOPUS:85100069361
VL - 64
SP - 150
EP - 183
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
SN - 0022-2623
IS - 1
ER -
ID: 73598376